Historical record - last NADAC effective date: 8/22/2013
This NDC is on FDA's drug shortage list (posted Apr 2, 2020)
Reported reason: Demand increase for the drug
Product Information
MIDAZOLAM HCL 1 MG/ML VIAL is a generic product labeled by Hospira Inc., priced at $0.2185 per ML under NDC 00409230505. Its NADAC has been published 1 times since Nov 28, 2013.
FDA first approved this application on Jul 22, 2002. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 mg/mL
Manufacturer
Hospira Inc.NDC
00409230505
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/22/2013
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075857FDA Approved
7/22/2002
TE Code
AP
On Market Since
8/17/2005
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 1 MG/ML VIAL has been published 1 times since Nov 28, 2013. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2185 per ML |
|---|---|
| All-time high | $0.2185 (Nov 28, 2013) |
| All-time low | $0.2185 (Nov 28, 2013) |
| Median price | $0.2185 |
| Average price | $0.2185 |
| Weeks tracked | 1 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
N/A
Last surveyed Nov 28, 2013 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MIDAZOLAM HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 1 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 1 MG/ML VIAL, manufactured by Hospira Inc., is $0.2185 per ML (NDC 00409230505), effective Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 1 MG/ML VIAL?
Since Nov 28, 2013, the NADAC for MIDAZOLAM HCL 1 MG/ML VIAL has ranged from a low of $0.2185 (Nov 28, 2013) to a high of $0.2185 (Nov 28, 2013), with a median of $0.2185 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 1 MG/ML VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDAZOLAM HCL 1 MG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures MIDAZOLAM HCL 1 MG/ML VIAL?
MIDAZOLAM HCL 1 MG/ML VIAL (NDC 00409230505) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is MIDAZOLAM HCL 1 MG/ML VIAL in shortage?
Yes — NDC 00409230505 is currently listed in FDA's drug shortage database (posted Apr 2, 2020). Reported reason: Demand increase for the drug.